ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ISO 9001:2015 Certified WHO-GMP PCD Pharma Franchise Company in India300+ Products Monopoly Rights Pan India DistributionCall us: +91-86533 91199
ARPOD-CV DRY SYP

MOXYM 500

Product Packing: 10X10

Product Composition: Amoxycillin 500 mg

Product Price: MRP : 791.7

MOXYM 500 Capsules

Amoxycillin 500 mg Capsules

MOXYM 500 is a prescription antibacterial formulation containing Amoxycillin 500 mg. Amoxycillin is an aminopenicillin beta-lactam antibiotic used for selected infections caused by susceptible bacteria, according to approved indications and clinical assessment.

Amoxycillin acts by binding to bacterial penicillin-binding proteins and inhibiting peptidoglycan cross-linking during cell-wall synthesis. This weakens the bacterial cell wall and can lead to cell lysis in susceptible organisms. Treatment should follow appropriate diagnosis, approved prescribing information and antimicrobial-stewardship principles.

Composition

Each capsule contains:

·         Amoxycillin - 500 mg

·         Excipients - q.s.

 

Dosage form: Capsule

Pack size: 10 x 10 capsules

Uses of MOXYM 500

MOXYM 500 may be prescribed for selected bacterial infections caused by susceptible organisms where Amoxycillin therapy is approved and clinically appropriate.

·         Treatment of selected ear, nose, throat and respiratory-tract bacterial infections according to approved prescribing information

·         Treatment of selected urinary-tract bacterial infections caused by susceptible organisms

·         Treatment of selected skin and soft-tissue bacterial infections where Amoxycillin is indicated

·         Other approved susceptible bacterial infections as determined by the treating clinician

Amoxycillin does not treat viral infections such as the common cold or influenza. Unnecessary or inappropriate antibiotic use contributes to antimicrobial resistance.

How MOXYM 500 Works

MOXYM 500 contains Amoxycillin, a beta-lactam antibacterial medicine:

Penicillin-binding proteins: Amoxycillin binds to bacterial penicillin-binding proteins involved in cell-wall construction.

Cell-wall synthesis inhibition: It interferes with peptidoglycan cross-linking, weakening the bacterial cell wall.

Bactericidal activity: Disruption of cell-wall integrity can lead to bacterial cell lysis in susceptible organisms.

Clinical response depends on infection site, organism susceptibility, dose, treatment duration and individual patient factors.

Dose selection and treatment duration must follow the approved product label and prescribing clinician's advice.

 

Dosage and Direction for Use

Use MOXYM 500 exactly as prescribed. Dose, frequency and duration depend on the diagnosed infection, age, kidney function, clinical response and other patient factors.

Swallow the capsule with water at the time and frequency directed by the prescriber. Follow the approved product label regarding administration with or without food.

Take doses at appropriately spaced intervals as directed. If a dose is missed, follow the approved label or prescriber's advice and do not double doses unless specifically instructed.

Complete the prescribed antibiotic course unless the treating healthcare professional advises otherwise. Renal impairment may require dose or interval adjustment.

Possible Side Effects

·         Possible unwanted effects may include:

·         Nausea, diarrhoea, vomiting or abdominal discomfort

·         Skin rash, itching or urticaria

·         Oral or vaginal candidiasis can occur during antibiotic therapy

·         Rare but serious effects can include severe allergic reactions, severe skin reactions, liver-related effects or antibiotic-associated diarrhoea including C. difficile-associated disease

·         Seek urgent medical attention for breathing difficulty, facial or throat swelling, severe rash, jaundice, severe weakness or persistent or bloody diarrhoea.

Persistent or troublesome adverse effects should be discussed with the treating healthcare professional.

Precautions and Contraindications

Before using MOXYM 500, the prescriber should review penicillin or cephalosporin allergy, kidney function, previous antibiotic-associated reactions and all concomitant medicines.

·         Do not use in patients with known serious hypersensitivity to Amoxycillin, penicillins or formulation ingredients according to approved prescribing information.

·         Cross-hypersensitivity can occur in patients with a history of reactions to other beta-lactam antibiotics, including cephalosporins.

·         Use caution in significant renal impairment because dose or dosing interval adjustment may be necessary.

·         A rash may occur more frequently when aminopenicillins are used in patients with infectious mononucleosis; appropriate diagnosis is important.

·         Antibiotic-associated diarrhoea, including C. difficile-associated disease, can occur during or after antibacterial treatment.

·         Pregnancy, breastfeeding, children, older adults and patients with significant chronic conditions require individualized professional guidance.

·         Keep out of reach of children and store according to the approved pack instructions.

·         Drug Interaction Considerations

·         Clinically relevant interaction considerations may include anticoagulants, allopurinol, probenecid, methotrexate and other medicines. The significance depends on the patient's regimen and clinical circumstances.

·         Patients should provide the prescriber with a complete list of prescription medicines, OTC products, vitamins, minerals and supplements before starting Amoxycillin.

Business Growth Opportunity with MOXYM 500

MOXYM 500 offers pharmaceutical distributors and healthcare entrepreneurs an opportunity to add an Amoxycillin 500 mg prescription antibacterial capsule to their anti-infective product portfolio.

Amoxycillin is an established antibacterial molecule. Promotion and use should support antimicrobial stewardship and remain strictly consistent with approved product information and applicable pharmaceutical regulations.

 

Key Business Advantages

·         Single-ingredient aminopenicillin antibacterial formulation

·         Amoxycillin 500 mg

·         Established beta-lactam antibacterial molecule

·         Convenient capsule dosage form

·         Suitable addition to anti-infective prescription portfolios where Amoxycillin use is clinically appropriate

·         Opportunity for ethical, stewardship-conscious promotion through appropriate healthcare channels

PCD Pharma Franchise Opportunity for MOXYM 500

Ethics Medinova Private Limited offers PCD Pharma Franchise opportunities for MOXYM 500 in selected territories across India, subject to availability, applicable regulations and mutually agreed business terms.

Franchise partners may benefit from the company's product portfolio, promotional support, supply coordination and business assistance.

 

Franchise Support May Include

·         Monopoly-based territory opportunities, subject to availability

·         Promotional materials and visual aids

·         Product information and marketing support

·         Reliable supply coordination

·         Access to a growing pharmaceutical product portfolio

·         Professional partner assistance

Partner with Ethics Medinova to explore PCD Pharma Franchise opportunities for MOXYM 500 and other quality-focused healthcare products.

Third-Party Manufacturing Support for Amoxycillin 500 mg Capsules

Ethics Medinova also supports eligible businesses exploring third-party manufacturing of formulations similar to MOXYM 500 under their own brand, subject to applicable licensing, prescription-drug, regulatory and manufacturing requirements.

Our third-party manufacturing support may include:

·         Customized product and pack requirements, subject to regulatory feasibility

·         Private-label manufacturing opportunities

·         Customized packaging and branding support

·         Product label and pack configuration assistance

·         Manufacturing coordination through suitable licensed facilities

·         Support for documentation and applicable regulatory requirements

This service may be suitable for eligible pharmaceutical companies and healthcare brands seeking to expand an anti-infective prescription product portfolio.

Frequently Asked Questions About MOXYM 500

1. What is MOXYM 500?

MOXYM 500 is a capsule formulation containing Amoxycillin 500 mg.

2. What is MOXYM 500 used for?

It may be prescribed for selected susceptible bacterial infections where Amoxycillin therapy is approved and clinically appropriate.

3. How should MOXYM 500 be taken?

Take MOXYM 500 exactly as prescribed by a qualified healthcare professional and complete the prescribed course unless advised otherwise.

4. Can MOXYM 500 be used for a common cold or flu?

No. Amoxycillin is an antibacterial medicine and does not treat viral infections such as the common cold or influenza.

5. Can people with penicillin allergy take MOXYM 500?

A history of penicillin or other beta-lactam allergy must be discussed with the prescriber. Serious hypersensitivity can occur and may contraindicate use.

6. Does kidney function affect Amoxycillin dosing?

Yes. Significant renal impairment can require dose or dosing-interval adjustment according to approved prescribing information.

7. Is a PCD Pharma Franchise available for MOXYM 500?

Yes. Ethics Medinova offers PCD Pharma Franchise opportunities for selected products and territories, subject to availability, applicable regulations and mutually agreed terms.

8. Can this formulation be manufactured under my own brand?

Eligible businesses interested in a similar Amoxycillin 500 mg capsule may explore third-party manufacturing and private-label support with Ethics Medinova, subject to applicable licensing and regulatory requirements.

Disclaimer

MOXYM 500 product information in this document is for general professional and business information. Exact approved indications, dosage, contraindications, warnings, interactions, susceptibility considerations, administration instructions, monitoring requirements, treatment duration, excipients and regulatory status must be verified against the current approved product label and applicable prescribing information before prescribing, dispensing, use or promotion. Antibiotics should be used responsibly under medical supervision to support antimicrobial stewardship. This document is not a substitute for professional medical advice.

Contact